Edition:
United States

AC Immune SA (ACIU.OQ)

ACIU.OQ on NASDAQ Stock Exchange Global Market

11.34USD
18 Jan 2019
Change (% chg)

$0.16 (+1.43%)
Prev Close
$11.18
Open
$11.11
Day's High
$11.47
Day's Low
$10.52
Volume
33,786
Avg. Vol
43,186
52-wk High
$17.39
52-wk Low
$7.21

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -- December 19 Jan 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 1 1 1
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.33 1.50 1.50 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Dec-19 3 8.66 19.07 0.00 10.02
Earnings (per share)
Year Ending Dec-19 3 -0.93 -0.89 -0.98 -1.01

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 1.02 2.28 1.26 123.13
Quarter Ending Jun-18 0.99 2.01 1.02 102.76
Quarter Ending Mar-18 2.14 1.46 0.68 31.83
Quarter Ending Dec-17 17.23 17.27 0.04 0.24
Quarter Ending Sep-17 7.97 1.08 6.89 86.47
Earnings (per share)
Quarter Ending Sep-18 -0.25 -0.21 0.05 -18.19
Quarter Ending Jun-18 -0.23 -0.19 0.04 -16.78
Quarter Ending Mar-18 -0.22 -0.20 0.02 -9.17
Quarter Ending Dec-17 0.01 0.08 0.08 824.18
Quarter Ending Sep-17 -0.13 -0.15 0.02 -15.66

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Dec-19 8.66 8.66 9.62 9.62 10.02
Earnings (per share)
Year Ending Dec-19 -0.93 -0.93 -0.95 -0.95 -1.01

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Dec-19 0 0 0 1
Earnings
Year Ending Dec-19 0 0 1 0